Docola, Inc. (DOCO)

Docola will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.75 - $6.75
Shares Offered
1,060,870
Deal Size
$6.63M

Company Description

Docola aims to be a social good organization offering a free care communication platform that seeks to consolidate thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one online marketplace called Docola.

Additionally, our Platform allows users to easily create and upload their own resources. With the use of our Platform, clinicians and patient-facing professionals can ePrescribe personalized information to an individual patient or groups of patients.

Patients can review the information and ask questions in the comfort of their own homes before, between, or after in-person or virtual visits.

We aim to enable healthcare providers to proactively meet people’s health informational needs, so they understand why it is important, possible, and safe to participate in their own medical care.

We aim to save time both for the patient and provider and improve patient satisfaction and patient outcomes.

To support the free version of the Platform, we offer optional paid services and license a separate product called DocolaRx, to research organizations, medical devices, biotech and pharmaceutical companies for their projects.

Docola, Inc.
Country United States
Founded 2013
Industry Internet Content & Information
Sector Communication Services
Employees 1
CEO Eran Kabakov

Contact Details

Address:
801 W. Bay Drive #506
Largo, FL 33770
United States
Phone (888) 981-8111
Website doco.la

Stock Details

Ticker Symbol DOCO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001644515
Employer ID 46-3626795
SIC Code 7374

Key Executives

Name Position
Eran Kabakov Chief Executive Officer, President
Itay Tsabari Chief Financial Officer
Tomer Kabakov Chief Operating Officer and Director
Jonathan Ascher Chief Medical Officer
Geri Lynn Baumblatt Chief Engagement Officer
Alexander Ellis Chief Technology Officer
Virginia Smith Independent Director
Jean Anne Booth Independent Director
Prasad Tare Independent Director

Latest SEC Filings

Date Type Title
Feb 1, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jan 2, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Dec 21, 2023 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Dec 20, 2023 8-A12B Registration of securities
Nov 20, 2023 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Oct 10, 2023 S-1 General form for registration of securities under the Securities Act of 1933
Sep 8, 2023 DRS/A [Amend] [Cover] Draft Registration Statement
Jan 23, 2023 DRS [Cover] Draft Registration Statement
May 24, 2016 D Notice of Exempt Offering of Securities